Last edition
News about "Schizophrenia Drug"
Schizophrenia and bi-polar drug gets FDA approval
The U.S. FDA has approved a new drug from BioXcel used to treat patients with schizophrenia or bipolar I or II disorder. BioXcel?s drug Igalmi was developed using the company?s artificial intelligence platform, marking a big step for the technology in the pharmaceutical industry, according to BioXcel.
Schizophrenia Drug | 27/04/2022 | By Sudeep Soparkar | 584
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members